primary prevention of coeliac disease - Associazione Italiana ...

More documents

Recommendations

Info

8 THE BASIS OF COELIAC DISEASE Acknowledgements Studies in the author's laboratory are funded by grants from the Research Council of Norway, the European Commission (BMH4-CT98-3087, QLRT-1999-00037, QLRT- 2000-00657), Medinnova, the Jahre Foundation and EXTRA funds from the Norwegian Foundation for Health and Rehabilitation. References 1. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120: 636-51. 2. Sollid LM. The molecular basis of celiac disease. Annu Rev Immunol 2000; 18: 53- 81. 3. Ellis A. Coeliac disease: previous family studies. In: McConnell RB, editor. The genetics of coeliac disease. Lancaster: MTP press, 1981: 197-9. 4. Polanco I, Biemond I, van Leeuwen A, Schreuder I, Meera Khan P, Guerrero J et al. Gluten sensitive enteropathy in Spain: Genetic and environmental factors. In: McConnell RB, editor. The genetics of coeliac disease. Lancaster: MTP Press, 1981: 211-31. 5. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987; 40: 1-14. 6. Petronzelli F, Bonamico M, Ferrante P, Grillo R, Mora B, Mariani P et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997; 61: 307-17. 7. Keuning JJ, Pena AS, van Leeuwen A, van Hooff JP, van Rood JJ. HLA-DW3 associated with coeliac disease. Lancet 1976; i: 506-8. 8. Ek J, Albrechtsen D, Solheim BG, Thorsby E. Strong association between the HLA- Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol 1978; 13: 229-33. 9. Mearin ML, Biemond I, Pena AS, Polanco I, Vazquez C, Schreuder GT et al. HLA- DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut 1983; 24: 532-7. 10. Trabace S, Giunta A, Rosso M, Marzorati D, Cascino I, Tettamanti A et al. HLA- ABC and DR antigens in celiac disease. A study in a pediatric Italian population. Vox Sang 1984; 46:102-6. 11. Tosi R, Vismara D, Tanigaki N, Ferrara GB, Cicimarra F, Buffolano W et al. Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol 1983; 28: 395-404. 12. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ a/bheterodimer. J Exp Med 1989; 169: 345-50. 13. Lin L, Jin L, Kimura A, Carrington M, Mignot E. DQ microsatellite association studies in three ethnic groups. Tissue Antigens 1997; 50: 507-20. 14. Lin L, Jin L, Lin X, Voros A, Underhill P, Mignot E. Microsatellite single nucleotide polymorphisms in the HLA-DQ region. Tissue Antigens 1998; 52: 9-18. 15. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping
THE BASIS OF COELIAC DISEASE 9 and role in pathogenesis. Gastroenterology 1993; 105: 910-22. 16. Greco L, Corazza G, Babron MC, Clot F, Fulchignoni-Lataud MC, Percopo S et al. Genome search in celiac disease. Am J Hum Genet 1998; 62: 669-75. 17. Greco L, Babron MC, Corazza GR, Percopo S, Sica R, Clot F et al. Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet 2001; 65: 35-41. 18. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat- Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998; 43: 187-9. 19. Naluai AT, Nilsson S, Samuelsson L, Gudjonsdottir AH, Ascher H, Ek J et al. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders. Tissue Antigens 2000; 56: 350-5. 20. Holopainen P, Arvas M, Sistonen P, Mustalahti K, Collin P, Maki M et al. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study. Tissue Antigens 1999; 53: 470-5. 21. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 2000; 165: 6606- 11. 22. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001; 2: 145- 52. 23. Kagnoff MF, Austin RK, Hubert JJ, Bernardin JE, Kasarda DD. Possible role for a human adenovirus in the pathogenesis of celiac disease. J Exp Med 1984; 160: 1544-57. 24. Mahon J, Blair GE, Wood GM, Scott BB, Losowsky MS, Howdle PD. Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. Gut 1991; 32:1114-6. 25. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995; 13: 587-622. 26. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM. Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol 1996; 8: 177-82. 27. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F. Peptide binding characteristics of the coeliac disease-associated DQa1*0501, b1*0201. molecule. Immunogenetics 1996; 44: 246-53. 28. Vartdal F, Johansen BH, Friede T, Thorpe C, Stevanovic S, Eriksen JA et al. The peptide binding motif of the disease associated HLA-DQa1*0501, b1*0201. molecule. Eur J Immunol 1996; 26: 2764-72. 29. Godkin A, Friede T, Davenport M, Stevanovic S, Willis A, Jewell D et al. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int Immunol 1997; 9: 905-11. 30. Kwok WW, Domeier ML, Raymond FC, Byers P, Nepom GT. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from
Page 1: Perspectives on Coeliac Disease Vol
Page 4: The AIC Meeting was held in the Aul
Page 8 and 9: Italian Coeliac Society, Via Picott
Page 11 and 12: Preface Coeliac disease (CD) is a u
Page 13: Contents Current understanding of t
Page 16 and 17: 2 THE BASIS OF COELIAC DISEASE hapl
Page 18 and 19: 4 THE BASIS OF COELIAC DISEASE 1 pr
Page 20 and 21: 6 THE BASIS OF COELIAC DISEASE spre
Page 24 and 25: 10 THE BASIS OF COELIAC DISEASE glu
Page 27 and 28: Catassi C, Fasano A, Corazza GR (ed
Page 29: T CELL RESPONSES TO GLUTEN PEPTIDES
Page 32 and 33: 18 A DOMINANT EPITOPE IN GLUTEN PEP
Page 42 and 43: 28 ROLE OF A-GLIADIN 31-49 PEPTIDE
Page 45 and 46: Catassi C, Fasano A, Corazza GR (ed
Page 47 and 48: COELIAC DISEASE IN THE SAHARAWI 33
Page 55: COELIAC DISEASE IN THE SAHARAWI 41
Page 58 and 59: 44 INFANT FEEDING PRACTICES AND COE
Page 66 and 67: Age (years) 52 INFANT FEEDING PRACT
Page 72 and 73:
58 INFANT FEEDING PRACTICES AND COE
Page 74 and 75:
60 INFANT FEEDING PRACTICES AND COE
Page 76 and 77:
62 MECHANISMS OF ORAL TOLERANCE the
Page 78 and 79:
64 MECHANISMS OF ORAL TOLERANCE pot
Page 80 and 81:
66 MECHANISMS OF ORAL TOLERANCE Epi
Page 82 and 83:
68 MECHANISMS OF ORAL TOLERANCE typ
Page 84 and 85:
70 MECHANISMS OF ORAL TOLERANCE 51
Page 86 and 87:
72 MECHANISMS OF ORAL TOLERANCE 23.
Page 89 and 90:
Catassi C, Fasano A, Corazza GR (ed
Page 91 and 92:
GENETICALLY DETOXIFIED GRAINS 77 to
Page 93 and 94:
• • GENETICALLY DETOXIFIED GRAI
Page 95 and 96:
GENETICALLY DETOXIFIED GRAINS 81 3.
Page 97 and 98:
Page 99 and 100:
IMMUNOTHERAPY OF COELIAC DISEASE 85
Page 101 and 102:
IMMUNOTHERAPY OF COELIAC DISEASE 87
Page 103 and 104:
Page 105 and 106:
RECENT ADVANCES ON GLUTEN TOXICITY
Page 107 and 108:
Index A Antiendomysium antibodies (
Page 109:
INDEX 95 W Wheat, 7, 23, 27, 31, 53
show all

primary prevention of coeliac disease - Associazione Italiana ...

Create successful ePaper yourself

Delete template?

Save as template?